Literature DB >> 8543205

Prevalence of dry eye in Japanese eye centers.

T Hikichi1, A Yoshida, Y Fukui, T Hamano, M Ri, K Araki, K Horimoto, E Takamura, K Kitagawa, M Oyama.   

Abstract

BACKGROUND: The purpose of the investigation was to ascertain the prevalence of dry eye in new outpatients.
METHODS: A total of 2127 consecutive new outpatients seen in eight Japanese centers from April 1992 to January 1993 underwent comprehensive examinations, including double vital staining and measurement of tear film break-up time, basal tear secretion, and tear clearance. Dry eye was diagnosed if patients had abnormalities of both the tear film and the ocular surface.
RESULTS: Three hundred fifty-nine patients (17%) had dry eye. There was no seasonal pattern for dry eye. The condition was significantly more common in Tokyo than in suburban areas (P < 0.01). The prevalence of dry eye in visual display terminal (VDT) users and contact lens (CL) wearers was significantly higher than in non-VDT users and non-CL wearers (P < 0.05 and P < 0.02, respectively).
CONCLUSION: Our findings suggest that dry eye is one of the most common ocular disorders encountered by physicians. Furthermore, if patients use VDTs or wear CLs, the likelihood of dry eye occurring is higher.

Entities:  

Mesh:

Year:  1995        PMID: 8543205     DOI: 10.1007/bf00404705

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  16 in total

1.  San Francisco passes ordinance regulating VDT use.

Authors:  J Foreman
Journal:  Arch Ophthalmol       Date:  1991-04

2.  Tear film: new concepts and implications for the management of the dry eye.

Authors:  M A Lemp
Journal:  Trans New Orleans Acad Ophthalmol       Date:  1987

3.  Contact lens wear in the management of the dry eye.

Authors:  R L Farris
Journal:  Int Ophthalmol Clin       Date:  1987

4.  A proposed mechanism for increased tear-film osmolarity in contact lens wearers.

Authors:  J P Gilbard; K L Gray; S R Rossi
Journal:  Am J Ophthalmol       Date:  1986-10-15       Impact factor: 5.258

5.  Diagnostic tests in the Sicca syndrome.

Authors:  O P van Bijsterveld
Journal:  Arch Ophthalmol       Date:  1969-07

Review 6.  Duke-Elder lecture. Prospects for the dry eye.

Authors:  A J Bron
Journal:  Trans Ophthalmol Soc U K       Date:  1985

7.  The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975.

Authors:  H M Leibowitz; D E Krueger; L R Maunder; R C Milton; M M Kini; H A Kahn; R J Nickerson; J Pool; T L Colton; J P Ganley; J I Loewenstein; T R Dawber
Journal:  Surv Ophthalmol       Date:  1980 May-Jun       Impact factor: 6.048

8.  Soft lens lubricants and prelens tear film stability.

Authors:  T R Golding; N Efron; N A Brennan
Journal:  Optom Vis Sci       Date:  1990-06       Impact factor: 1.973

Review 9.  Tear physiology and dry eyes.

Authors:  F J Holly; M A Lemp
Journal:  Surv Ophthalmol       Date:  1977 Sep-Oct       Impact factor: 6.048

10.  Increased tear evaporation in eyes with keratoconjunctivitis sicca.

Authors:  M Rolando; M F Refojo; K R Kenyon
Journal:  Arch Ophthalmol       Date:  1983-04
View more
  33 in total

1.  Characteristics of spontaneous eyeblink activity during video display terminal use in healthy volunteers.

Authors:  Nora Freudenthaler; Hartmut Neuf; Gregor Kadner; Torsten Schlote
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-10-25       Impact factor: 3.117

2.  Correlation between optical coherence tomography-derived assessments of lower tear meniscus parameters and clinical features of dry eye disease.

Authors:  Pho Nguyen; David Huang; Yan Li; Srinivas R Sadda; Sylvia Ramos; Rajeev R Pappuru; Samuel C Yiu
Journal:  Cornea       Date:  2012-06       Impact factor: 2.651

3.  Dry eye after haematopoietic stem cell transplantation.

Authors:  Y Ogawa; S Okamoto; M Wakui; R Watanabe; M Yamada; M Yoshino; M Ono; H Y Yang; Y Mashima; Y Oguchi; Y Ikeda; K Tsubota
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

4.  Diseases associated with ocular surface abnormalities: the importance of reflex tearing.

Authors:  K Tsubota; M Kaido; Y Yagi; T Fujihara; S Shimmura
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

5.  Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: implication for daily clinical practice.

Authors:  G Giannaccare; F Bonifazi; M Sessa; E Dan; M Arpinati; M Fresina; G Bandini; M Cavo; P Versura; E C Campos
Journal:  Eye (Lond)       Date:  2017-05-19       Impact factor: 3.775

6.  Prevalence and risk factors of dry eye syndrome in a United States veterans affairs population.

Authors:  Anat Galor; William Feuer; David J Lee; Hermes Florez; David Carter; Bozorgmehr Pouyeh; William J Prunty; Victor L Perez
Journal:  Am J Ophthalmol       Date:  2011-09       Impact factor: 5.258

Review 7.  Neuropathic ocular pain: an important yet underevaluated feature of dry eye.

Authors:  A Galor; R C Levitt; E R Felix; E R Martin; C D Sarantopoulos
Journal:  Eye (Lond)       Date:  2014-11-07       Impact factor: 3.775

Review 8.  [Blinking activity during visual display terminal work. Part 1: Ocular discomfort and pathophysiological principles].

Authors:  F Ziemssen; N Freudenthaler; K Regnery; T Schlote
Journal:  Ophthalmologe       Date:  2005-08       Impact factor: 1.059

Review 9.  Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia.

Authors:  A J Lee; J Lee; S-M Saw; G Gazzard; D Koh; D Widjaja; D T H Tan
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

10.  Marked reduction and distinct patterns of eye blinking in patients with moderately dry eyes during video display terminal use.

Authors:  Torsten Schlote; Gregor Kadner; Nora Freudenthaler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-01-28       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.